Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

NCT03640650 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

80

Enrollment

OTHER

Sponsor class

Stopped COVID-19 pandemic leading to uncertainty in the recruitement

Conditions

Cataract Surgery

Interventions

COMBINATION_PRODUCT: Dropless Therapy
DRUG: Usual Care

Sponsor

PeriPharm

Collaborators

[object Object]
[object Object]